Data availability :
The data that support the findings of this study are available from the
corresponding author (M.Y) upon reasonable request.
References:
- Quinn M, Babb P. Patterns and trends in prostate cancer.
Incidence, survival, prevalence and mortality. Part 1: international
comparisons. B JU Int. 2002;90(2):162-173
- Ferro MA, Barnes I, Roberts JBM, Smith PJB . Tumour markers in
prostatic carcinoma: a comparison of prostate-specific antigen with
acid phosphatase. Br J Urol 1987;60:69-73
- Braun K, Sjoberg DD, Vickers AJ, et al . A fourkallikrein panel
predicts high grade cancer on biopsy: independent validation in a
community cohort. E. Urol. 2016;69:505-511
- Zappala S, Scardino P, Okrongly D, et al . Clinical performance
of the 4K®score to test to predict high-grade prostate cancer at
biopsy:A meta-analysis of US and European clinical validation study
results.Rev Urol. 2017; 19(3):149-155
- Punnen S, Pavan N, Parekh DJ . Finding the wolf in sheep’s
clothing: the 4K®score Test is a novel blood test that can acuurately
identify the risk of aggressive prostate cancer. Rev Urol.
2015;17:3-13
- Stattin P, Vickers AJ, Sjoberg DD et al. Eur Urol. 2015
Aug;68(2):207-13.
- Voigt JD, Dong Y, Linder V, Zappala S . Use of the 4K®score test
to predict the risk of aggressive prostate cancer prior to prostate
biopsy: overall cost savings and improved quality of care to the US
healthcare system. Rev Urol. 2017;19:1-10
- Kutikov A, Weinberg D, Edelman M, et al . A war on two fronts:
cancer care in the time of COVID-19. Ann Intern Med 2020; Mar 27 :
M20-1133
- Kaufman H, Chen Z, Niles J, Fesko Y . Changes in the Number of
US Patients With Newly Identified Cancer Before and During the
Coronavirus Disease 2019 (COVID-19) Pandemic. JAMA Netw. Open.
2020;3(8). E
- Maringe C, Spicer J, Morris M, et al . The impact of the
COVID-19 pandemic on cancer deaths due to delays in diagnosis in
England, UK: a national, population-based, modelling study. Lancet
Oncol. 2020;21(8): 1023-1034
- Center M, Jemal A, Lortet-Tieulent J, et al. International
variation in prostate cancer incidence and mortality rates. Eur Urol.
2012; 61(6). 1079-1092
- Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA
Cancer J Clin. 2014;64:9-29
- Dall’Era MA, Albertsen PC, Bangma C, et al. Active surveillance for
prostate cancer: a systematic review of the literature. Eur
Urol. 2012;62:976–983
- Punnen S, Cooperberg MR. The epidemiology of high-risk prostate
cancer. Curr Opin Urol. 2013;23:331–336
- Jordan R, Adab P, Cheng KK . COVID-19: risk factors for severe
disease and death. BMJ. 2020
- Vrdoljak E, Sullivan R, Lawlwe M . Cancer and corona virus
disease 2019; how do we manage cancer optimally through a public
health crisis? Eur J Cancer. 2020;132:98-99
- Mazza C, Ricci E, Siondi S . A nationwide survey of
psychological distress among Italian people during the COVID-19
pandemic: immediate psychological responses and associated factors.
Int J Environ Res Public Health. 2020;17(9):3165
- Savin Z, Dekalo S, Marom R, et al . The effect of delaying
transperineal fusion biopsy of the prostate for patients with
suspicious MRI findings- implications for the COVID-19 era. Urol
Oncol. 2021;39(1). 73.e1-73e8